Evidence map›Paper›PMID 37546768›Full record

ArticlemedRxiv : the preprint server for health sciences2023

Comparison of cardiovascular health profiles across population surveys from five high- to low-income countries.

Lisa Ware, Bridget Vermeulen, Innocent Maposa, David Floo, Luisa Cc Brant, Shweta Khandelwal, Kavita Singh, Sara Soares, Neusa Jessen, Gastón Perman and 4 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Lisa WareSouth African MRC Developmental Pathways for Health Research Unit, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Bridget VermeulenSouth African MRC Developmental Pathways for Health Research Unit, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Innocent MaposaDivision of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
David FlooWuqu' Kawoq, Santiago Sacatepéquez, Sacatepéquez, Guatemala.
Luisa Cc BrantFaculty of Medicine, Universidade Federal de Minas Gerais, Brazil.
Shweta KhandelwalPublic Health Foundation of India, Delhi, India.
Kavita SinghHeidelberg Institute of Global Health, Heidelberg University, Germany.
Sara SoaresEPIUnit - Instituto de Saúde Pública, Universidade do Porto, Portugal.
Neusa JessenFaculty of Medicine, Eduardo Mondlane University, Mozambique.
Gastón PermanDepartment of Public Health. Instituto Universitario Hospital Italiano de Buenos Aires, Argentina.
Baizid Khoorshid RiazNational Institute of Preventive & Social Medicine (NIPSOM), Ministry of Health & Family Welfare, Mohakhali, Dhaka, Bangladesh.
Harshpal Singh SachdevSitaram Bhartia Institute of Science and Research, New Delhi 110016, India.
Norrina B AllenDepartment of Preventive Medicine, Feinberg School of Medicine, Northwestern University, USA.
Darwin R LabartheDepartment of Preventive Medicine, Feinberg School of Medicine, Northwestern University, USA.

Funding

Implementation research for comprehensive cardiometabolic care in GuatemalaK23HL161271 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David Clifford Flood · 2022 to 2026
$949k
Developing and testing Collaborative Quality ImProvement initiative (C-QIP) for prevention of cardiovascular disease in IndiaK43TW011164 · FIC · PUBLIC HEALTH FOUNDATION OF INDIA · PI SINGH, KAVITA · 2019 to 2023
$342k
FIC NIH HHS K43 TW011164NHLBI NIH HHS K23 HL161271
6 · The paper itself

Abstract

Aims: With the greatest burden of cardiovascular disease morbidity and mortality increasingly observed in lower-income countries least prepared for this epidemic, focus is widening from risk factor management alone to primordial prevention to maintain high levels of cardiovascular health (CVH) across the life course. To facilitate this, the American Heart Association (AHA) developed CVH scoring guidelines to evaluate and track CVH. We aimed to compare the prevalence and trajectories of high CVH across the life course using nationally representative adult CVH data from five diverse high- to low-income countries. Methods: Surveys with CVH variables (physical activity, cigarette smoking, body mass, blood pressure, blood glucose, and total cholesterol levels) were identified in Ethiopia, Bangladesh, Brazil, England, and the United States (US). Participants were included if they were 18-69y, not pregnant, and had data for these CVH metrics. Comparable data were harmonized and each of the CVH metrics was scored using AHA guidelines as high (2), moderate (1), or low (0) to create total CVH scores with higher scores representing better CVH. High CVH prevalence by age was compared creating country CVH trajectories. Results: The analysis included 28,092 adults (Ethiopia n=7686, 55.2% male; Bangladesh n=6731, 48.4% male; Brazil n=7241, 47.9 % male; England n=2691, 49.5% male, and the US n=3743, 50.3% male). As country income level increased, prevalence of high CVH decreased (>90% in Ethiopia, >68% in Bangladesh and under 65% in the remaining countries). This pattern remained using either five or all six CVH metrics and following exclusion of underweight participants. While a decline in CVH with age was observed for all countries, higher income countries showed lower prevalence of high CVH already by age 18y. Excess body weight appeared the main driver of poor CVH in higher income countries, while current smoking was highest in Bangladesh. Conclusion: Harmonization of nationally representative survey data on CVH trajectories with age in 5 highly diverse countries supports our hypothesis that CVH decline with age may be universal. Interventions to promote and preserve high CVH throughout the life course are needed in all populations, tailored to country-specific time courses of the decline. In countries where CVH remains relatively high, protection of whole societies from risk factor epidemics may still be feasible.

Indexed as

cardiovascularpopulation healthpreventionrisk behavior

Identifiers

PMID37546768
PMCPMC10402230

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.